joshy russoDr. Joshua Russo joined Dr. Balk's laboratory in 2015. He is studying the mechanisms of abiraterone resistance in castrate-resistant prostate cancer (CRPC). Previously, he was a pathology resident at Beth Israel Deaconess Medical Center. Prior to residency, he completed the M.D., Ph.D. program at Tufts University School of Medicine with a Ph.D. research focus in the Pathophysiology and Medical Management of Uterine Leiomyoma.

Email Dr. Russo

Publications (click underlined to go to publication):

1. Russo JW and Castellot J. CCN5: biology and pathophysiology. J Cell Commun Signal. 2010;4(3):119-20.

2. Wiesman KC, Wei L, Baughman C, Russo J, Gray MR, Castellot JJ. CCN5, a secreted protein, localizes to the nucleus . J Cell Commun Signal. 2010;4(2):91-98.

3. Wei L, McKeon F, Russo JW, Lemire J, Castellot J. Domain and species specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5. J Cell Commun Signal. 2009;3(1):65-77.

4. Salem RO, Refaai MA, Cluette-Brown JE, Russo JW, Laposata M. Fatty acid ethyl esters in liver and adipose tissues as postmortem markers for ethanol intake. Clin Chem. 2001;47(4):722-5.

5. Ratto JA, Russo JW, Allen A, Herbert J, Wirsen C. Biodegradable Polymers in the Marine Environment: A Tiered Approach to Assessing Microbial Degradability. In: Gross R, Sholtz C, eds. Polymers from Renewable Resources: Carbohydrates and Agro proteins, American Chemical Society Symposium Series, Oxford Press, Dec 2000.